269 related articles for article (PubMed ID: 34619654)
21. Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease.
Li KR; Avecillas-Chasin J; Nguyen TD; Gillen KM; Dimov A; Chang E; Skudin C; Kopell BH; Wang Y; Shtilbans A
J Neuroimaging; 2022 Mar; 32(2):363-371. PubMed ID: 34904328
[TBL] [Abstract][Full Text] [Related]
22. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
[TBL] [Abstract][Full Text] [Related]
23. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
24. Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.
Zhang X; Li L; Qi L; Fu Y; Sun D; Chen S; Xu W; Liu C; Zhou X; He G
Neurosci Lett; 2023 Jun; 807():137249. PubMed ID: 37061026
[TBL] [Abstract][Full Text] [Related]
25. Diffusion Kurtosis Imaging of Substantia Nigra Is a Sensitive Method for Early Diagnosis and Disease Evaluation in Parkinson's Disease.
Zhang G; Zhang Y; Zhang C; Wang Y; Ma G; Nie K; Xie H; Liu J; Wang L
Parkinsons Dis; 2015; 2015():207624. PubMed ID: 26770867
[TBL] [Abstract][Full Text] [Related]
26. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O
PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763
[TBL] [Abstract][Full Text] [Related]
27. Quantitative assessment of iron deposition in Parkinson's disease using enhanced T2 star-weighted angiography.
Ji S; Zhang S; Mao Z; Han H; Yang Q; Zhu W; Zhu S; Xue Z
Neurol India; 2016; 64(3):428-35. PubMed ID: 27147149
[TBL] [Abstract][Full Text] [Related]
28. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
Arribarat G; Pasternak O; De Barros A; Galitzky M; Rascol O; Péran P
Parkinsonism Relat Disord; 2019 Aug; 65():146-152. PubMed ID: 31182373
[TBL] [Abstract][Full Text] [Related]
29. Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
Esterhammer R; Seppi K; Reiter E; Pinter B; Mueller C; Kremser C; Zitzelsberger T; Nocker M; Scherfler C; Poewe W; Schocke M
PLoS One; 2015; 10(12):e0145493. PubMed ID: 26713760
[TBL] [Abstract][Full Text] [Related]
30. Quantitative susceptibility mapping in atypical Parkinsonisms.
Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
Saikiran P;
Neurol India; 2020; 68(2):278-281. PubMed ID: 32415005
[TBL] [Abstract][Full Text] [Related]
32. Alteration of putaminal fractional anisotropy in Parkinson's disease: a longitudinal diffusion kurtosis imaging study.
Surova Y; Nilsson M; Lampinen B; Lätt J; Hall S; Widner H; van Westen D; Hansson O
Neuroradiology; 2018 Mar; 60(3):247-254. PubMed ID: 29368035
[TBL] [Abstract][Full Text] [Related]
33. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
[TBL] [Abstract][Full Text] [Related]
34. Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study.
Shin C; Lee S; Lee JY; Rhim JH; Park SW
J Korean Med Sci; 2018 Mar; 33(13):e96. PubMed ID: 29573246
[TBL] [Abstract][Full Text] [Related]
35. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
Zhang J; Zhang Y; Wang J; Cai P; Luo C; Qian Z; Dai Y; Feng H
Brain Res; 2010 May; 1330():124-30. PubMed ID: 20303339
[TBL] [Abstract][Full Text] [Related]
36. Time-Specific Pattern of Iron Deposition in Different Regions in Parkinson's Disease Measured by Quantitative Susceptibility Mapping.
Fu X; Deng W; Cui X; Zhou X; Song W; Pan M; Chi X; Xu J; Jiang Y; Wang Q; Xu Y
Front Neurol; 2021; 12():631210. PubMed ID: 34421781
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2
Cheng Q; Huang J; Liang J; Ma M; Zhao Q; Lei X; Shi C; Luo L
Exp Ther Med; 2020 Jun; 19(6):3778-3786. PubMed ID: 32346442
[TBL] [Abstract][Full Text] [Related]
38. Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson's Disease.
Zhang D; Yao J; Sun J; Tong Q; Zhu S; Wang J; Chen L; Ma J; He H; Wu T
J Parkinsons Dis; 2022; 12(8):2469-2478. PubMed ID: 36404557
[TBL] [Abstract][Full Text] [Related]
39. Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping.
Ito K; Ohtsuka C; Yoshioka K; Kameda H; Yokosawa S; Sato R; Terayama Y; Sasaki M
Neuroradiology; 2017 Aug; 59(8):759-769. PubMed ID: 28689259
[TBL] [Abstract][Full Text] [Related]
40. An automatic interpretable deep learning pipeline for accurate Parkinson's disease diagnosis using quantitative susceptibility mapping and T1-weighted images.
Wang Y; He N; Zhang C; Zhang Y; Wang C; Huang P; Jin Z; Li Y; Cheng Z; Liu Y; Wang X; Chen C; Cheng J; Liu F; Haacke EM; Chen S; Yang G; Yan F
Hum Brain Mapp; 2023 Aug; 44(12):4426-4438. PubMed ID: 37335041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
